Drug Search Results
More Filters [+]

Altanserin

Alternative Names: altanserin
Latest Update: 2024-10-01
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: 5-HT2A Binder

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Hospices Civils de Lyon
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Altanserin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Tourette Syndrome|Rett Syndrome

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

69HCL22_0683

P2

Unknown Status

Tourette Syndrome|Rett Syndrome

2028-10-01

2019-000340-99

P2

Completed

Unknown

2023-04-26

Park-IMPULSE

N/A

Unknown status

Conduct Disorder|Parkinson's Disease

2022-02-13

Recent News Events